Mit Commitments internationaler Pensionsfonds, Banken, Fund-of-Funds, Endowments und Family Offices erreicht Gilde Healthcare ein erstes Closing in Höhe von €250 Mio Die Erweiterung um Climate Solutions baut auf Gilde Healthcare‘s Erfolgsbilanz im Bereich des Impact...

New investment fuels expansion as leading health systems adopt evidence-based digital care, driven by new billing codes and strong demand for proven mental health solutions. Big Health, a leading developer of digital treatments for the...

SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the pricing of its initial public offering of 9,375,000 shares of its common stock at a public offering price of $16.00 per...